DexCom Is Great. Here's Why You Shouldn't Buy It.
DexCom ( DXCM -2.62%) is not a stock that investors should be rushing to sell. It has a few different opportunities to ...
Is DexCom a Millionaire Maker?
With the company's market cap of $28 billion today, it's important to recognize that DexCom (NASDAQ: DXCM) is already one of ...
DexCom: Investors Discounting Long CGM Growth Runway
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
DXCM FRAUD ALERT: BFA Law Notifies DexCom, Inc. Investors who Suffered Losses to Contact the Firm by the October 21 Class Action Deadline
New York, New York-- (Newsfile Corp. - September 26, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and ...
Business Wire19h
Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2024 financial results after market close on Thursday, October 24, 2024. Management ...
Nasdaq7h
What the Options Market Tells Us About DexCom
Investors with a lot of money to spend have taken a bullish stance on DexCom (NASDAQ:DXCM). And retail traders should know. We noticed this today when the trades showed up on publicly available ...
FiercePharma3d
Dexcom picks 'Parks & Rec' star Retta to launch Glucose Awareness Week, with push for OTC Stelo sensor
More than a decade after coining “Treat Yo’ Self Day” in her role as Donna on “Parks & Recreation,” Retta is once again ...
DexCom Inc. stock underperforms Tuesday when compared to competitors
Shares of DexCom Inc. DXCM slipped 1.49% to $68.66 Tuesday, on what proved to be an all-around favorable trading session for ...
Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims On Behalf Of Investors Of Dexcom
Investors and analysts reacted immediately to DexCom's revelation. The price of DexCom's common stock declined dramatically.
DXCM INVESTOR DEADLINE: If You Suffered Losses on Your DexCom, Inc. Investment, Contact BFA Law before October 21 Legal Deadline
New York, New York-- (Newsfile Corp. - September 25, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and ...